Skip to content
Back to recalls
Drug FDA Class I Terminated Foreign material

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Gilead Sciences, Inc. Published Oct 9, 2024

Risk level

Class I

Dangerous or defective — could cause serious health problems or death.

Severity score 80/100

What should you do?

  • Check whether you have this product, using the lot codes, UPCs, and dates listed below.
  • Do not eat, serve, or sell the affected product.
  • Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
  • Contact Gilead Sciences, Inc. or your place of purchase with questions, and see the source record below for full details.
Reason for recall

Presence of Particulate Matter: Presence of glass particle.

Hazards

Glass · primary

Affected products (1)

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

VEKLURY · 105,000 vials

NDC: 61958-2901, 61958-2902, 61958-2902-2, 61958-2901-2
Lot codes: 47035CFA
Code info: Lot: 47035CFA, Exp. 11/2025

Affected areas

Nationwide

Timeline

  1. Initiated
    Sep 19, 2024
  2. Published
    Oct 9, 2024
  3. Terminated
    Jul 29, 2025
Recall number
D-0005-2025
Agency
U.S. Food and Drug Administration
Country
US
Source data (openFDA JSON) About FDA enforcement reports

FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.